Clinical Trials Browser

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

NCT07516210 2026-04-07

ART-Hypo

Phase 2 Not yet recruiting

264 enrolled

GastrointestinalGenitourinaryGynecologic

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Phase 2 Not yet recruiting

180 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07369986 2026-01-27

IMMUNE-SAVE

Phase 2 Not yet recruiting

30 enrolled

Gynecologic

Turcot syndrome, Endometrial Neoplasms

NCT07139977 2026-01-20

EV-4-EC

Phase 2 Not yet recruiting

12 enrolled

Gynecologic

Endometrial Neoplasms

NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

40 enrolled

GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07170982 2025-09-12

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Phase 2 Not yet recruiting

128 enrolled

Gynecologic

Endometrial Neoplasms

NCT07115927 2025-08-19

RODEO

Phase 2 Not yet recruiting

40 enrolled

Gynecologic

Endometrial Neoplasms

NCT06942377 2025-07-08

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Phase 2 Not yet recruiting

140 enrolled

Gynecologic

Endometrial Neoplasms

NCT06073184 2025-06-10

WE-FiERCE

Phase 2 Not yet recruiting

71 enrolled

Gynecologic

Endometrial Neoplasms

NCT06771154 2025-01-13

A-CAPE

Phase 2 Not yet recruiting

140 enrolled

Gynecologic

Endometrial Neoplasms

NCT06751277 2024-12-27

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Phase 2 Not yet recruiting

26 enrolled

Gynecologic

Recurrence, Endometrial Neoplasms

NCT06548763 2024-08-12

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Phase 2 Not yet recruiting

30 enrolled

Gynecologic

Endometrial Neoplasms

NCT06297811 2024-03-07

Myeloprotection With Trilaciclib in Pan-cancer Population

Phase 2 Not yet recruiting

132 enrolled

BreastGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Phase 2 Not yet recruiting

45 enrolled

Gynecologic

Endometrial Neoplasms

NCT06183736 2023-12-27

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Phase 2 Not yet recruiting

98 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05805358 2023-08-30

DNPSPIO

Phase 2 Not yet recruiting

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05550558 2022-09-28

CAN-RESPOND

Phase 2 Not yet recruiting

43 enrolled

Gynecologic

Endometrial Neoplasms

Clinical Trials

MITO END-4

ART-Hypo

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

IMMUNE-SAVE

EV-4-EC

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

RODEO

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

WE-FiERCE

A-CAPE

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Myeloprotection With Trilaciclib in Pan-cancer Population

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

DNPSPIO

CAN-RESPOND